• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Transient Ischemic Attack (2109); Cardiac Tamponade (2226)
Event Date 06/16/2021
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, 800 consecutive patients underwent transcatheter patent foramen ovale closure between january 1995 and may 2010; amplatzer pfo occluder and amplatzer cribriform occuder (abbott), cardioform and helex pfo occluder (w.L.Gore and associates) and cardioseal starflex septal occluder(nitonal medical technologies) were associated with the study.Events of stroke, transient ischemic attack, tamponade, device embolization, deep venous thrombosis, tricuspid valve damage, residual shunt, and re-intervention were reported.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
Related manufacturing reference number: (b)(4).The article, "efficacy and safety of percutaneous patent foramen ovale closure in patients with a hypercoagulable disorder", was reviewed.This research article is a retrospective single center experience to compare the safety and efficacy of percutaneous patent foramen ovale (pfo) closure in patients with and without a hypercoagulable state.Amplatzer pfo occluder and amplatzer cribriform occuder (abbott), cardioform and helex pfo occluder (w.L.Gore and associates) and cardioseal starflex septal occluder(nitonal medical technologies) were associated with the study.The article concluded that percutaneous pfo closure is a safe and effective therapeutic approach for patients with cryptogenic stroke and an underlying hypercoagulable state.The primary and correspondence author of the article is (b)(6).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
ABBOTT MEDICAL
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key12274250
MDR Text Key264967917
Report Number2135147-2021-00303
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 08/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/06/2021
Initial Date FDA Received08/04/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age50 YR
-
-